PATENT CLAIM ANALYSIS

Application Number: 15939066
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 25):
The method of  claim 15 , wherein the at least one species of  Roseomonas  genus bacterium is topically administered to the subject at least two times per a week.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15662691', '13394113', '14286308', '15556953', '15775085']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6756106891065866
- 35 USC 102 Novelty (BERT): 0.4963565637575443
- Combined Prediction Score: 0.6576852765716824
- Mean Citation Score: 163.15910200000005
- Max Citation Score: 188.28313
- Similarity Product: 129.73146656185926

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test